CANC vs. GNOM ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Global X Genomics & Biotechnology ETF (GNOM)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$28.47
Average Daily Volume
6,896
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$10.68
Average Daily Volume
54,097
Number of Holdings
*
39
* may have additional holdings in another (foreign) market
Performance
| Period | CANC | GNOM |
|---|---|---|
| 30 Days | 4.32% | -1.20% |
| 60 Days | 4.40% | 2.40% |
| 90 Days | 3.75% | 2.50% |
| 12 Months | 16.09% | -3.17% |
1 Overlapping Holdings
| Symbol | Grade | Weight in CANC | Weight in GNOM | Overlap | |
|---|---|---|---|---|---|
| ILMN | B | 3.1% | 3.79% | 3.1% |
CANC Underweight 38 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| ALNY | C | -6.94% | |
| RNA | D | -5.22% | |
| RARE | B | -4.47% | |
| NTRA | B | -4.41% | |
| LEGN | D | -4.37% | |
| MYGN | B | -4.18% | |
| TECH | D | -4.08% | |
| VCYT | B | -4.05% | |
| SRPT | D | -3.84% | |
| QGEN | B | -3.83% | |
| NTLA | F | -3.72% | |
| A | B | -3.6% | |
| ARWR | F | -3.59% | |
| BMRN | D | -3.48% | |
| BNTX | C | -3.46% | |
| BEAM | F | -3.12% | |
| CRSP | F | -2.97% | |
| TXG | D | -2.89% | |
| RCKT | F | -2.71% | |
| CDNA | B | -2.61% | |
| MRNA | F | -2.48% | |
| VRTX | D | -2.13% | |
| GILD | A | -2.06% | |
| VIR | F | -1.27% | |
| SANA | D | -1.26% | |
| RGNX | F | -0.91% | |
| FLGT | D | -0.79% | |
| PACB | F | -0.6% | |
| VERV | F | -0.57% | |
| EDIT | F | -0.51% | |
| ALLO | F | -0.48% | |
| QURE | F | -0.45% | |
| TSVT | C | -0.39% | |
| PSTX | F | -0.34% | |
| LYEL | F | -0.29% | |
| CRBU | F | -0.28% | |
| BLUE | F | -0.19% | |
| SCLX | F | -0.07% |
CANC: Top Represented Industries & Keywords
Industries:
Biotechnology
Drug Manufacturers - Major
Diagnostics & Research
Keywords:
Biotechnology
Medicine
Cancer
Inflammation
Nasdaq 100
S&P 500
Biopharmaceutical
Bone
Clinical Research
Dow Jones Component
Infectious Diseases
Life Sciences
Obesity
Ophthalmology
Pharmaceutical Products
Prostate Cancer
Resistant Prostate Cancer
Rheumatoid Arthritis
Acid
Acute Myeloid Leukemia
GNOM: Top Represented Industries & Keywords
Compare ETFs
